{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T09:26:02Z","timestamp":1771665962790,"version":"3.50.1"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CVIR Endovasc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    This retrospective study evaluates post-procedural symptom score changes after prostate artery embolization (PAE) with (Coil-out) and without (Standard) adjunctive prostate artery coiling after particle embolization. Changes in IPSS, QOL\/Bother, and SHIM-IIEF V are reported at 1\u20135- and 9\u201315-month intervals. 573 procedures were reviewed, and 317 patients were included with a mean age of 72.1\u00a0years. Results favored the Standard group with greater IPSS reduction at 1\u20135 (-12.2 vs. -9.9,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.018) and 9\u201315\u00a0months (-12.5 vs. -7.6,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.018), and greater QOL\/Bother improvement in the Standard group at 9\u201315\u00a0months (-2.8 vs. -1.8,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.014). Procedure times were longer in the Standard group (186 vs. 173\u00a0min;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.039), whereas fluoroscopy times were longer in the Coil-out group (48.3 vs. 44.8\u00a0min;\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.014). Though limited by retrospective nature and lack of longer-term follow-up, these results support particle embolization alone over adjunctive coil embolization for PAE.\n                  <\/jats:p>","DOI":"10.1186\/s42155-026-00660-4","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:42:58Z","timestamp":1771663378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Coil-out: comparing outcomes after prostate artery embolization with and without endovascular coiling"],"prefix":"10.1186","volume":"9","author":[{"given":"Griffin P. J.","family":"McNamara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucas R.","family":"Cusumano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin P.","family":"McWilliams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,21]]},"reference":[{"issue":"4","key":"660_CR1","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1097\/01.ju.0000155709.37840.fe","volume":"173","author":"JT Wei","year":"2005","unstructured":"Wei JT, Calhoun E, Jacobsen SJ. Urologic diseases in America project: benign prostatic hyperplasia. J Urol. 2005;173(4):1256\u201361.","journal-title":"J Urol"},{"issue":"1","key":"660_CR2","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.carj.2016.06.003","volume":"68","author":"A Mirakhur","year":"2017","unstructured":"Mirakhur A, McWilliams JP. Prostate artery embolization for benign prostatic hyperplasia: current status. Can Assoc Radiol J. 2017;68(1):84\u20139.","journal-title":"Can Assoc Radiol J"},{"issue":"1","key":"660_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1097\/JU.0000000000003698","volume":"211","author":"JS Sandhu","year":"2024","unstructured":"Sandhu JS, et al. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline amendment 2023. J Urol. 2024;211(1):11\u20139.","journal-title":"J Urol"},{"issue":"5","key":"660_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.jvir.2019.02.013","volume":"30","author":"JP McWilliams","year":"2019","unstructured":"McWilliams JP, et al. Society of Interventional Radiology Multisociety Consensus Position Statement on Prostatic Artery Embolization for Treatment of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: From the Society of Interventional Radiology, the Cardiovascular and Interventional Radiological Society of Europe, Soci\u00e9t\u00e9 Fran\u00e7aise de Radiologie, and the British Society of Interventional Radiology: Endorsed by the Asia Pacific Society of Cardiovascular and Interventional Radiology, Canadian Association for Interventional Radiology, Chinese College of Interventionalists, Interventional Radiology Society of Australasia, Japanese Society of Interventional Radiology, and Korean Society of Interventional Radiology. J Vasc Interv Radiol. 2019;30(5):627-637. e1.","journal-title":"J Vasc Interv Radiol"},{"key":"660_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2338","author":"D Abt","year":"2018","unstructured":"Abt D, et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. BMJ. 2018. https:\/\/doi.org\/10.1136\/bmj.k2338.","journal-title":"BMJ"},{"key":"660_CR6","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s00270-015-1202-4","volume":"39","author":"FC Carnevale","year":"2016","unstructured":"Carnevale FC, et al. Transurethral resection of the prostate (TURP) versus original and PErFecTED prostate artery embolization (PAE) due to benign prostatic hyperplasia (BPH): preliminary results of a single center, prospective, urodynamic-controlled analysis. Cardiovasc Intervent Radiol. 2016;39:44\u201352.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"6","key":"660_CR7","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/S1051-0443(07)61638-8","volume":"11","author":"JS DeMeritt","year":"2000","unstructured":"DeMeritt JS, et al. Relief of benign prostatic hyperplasia-related bladder outlet obstruction after transarterial polyvinyl alcohol prostate embolization. J Vasc Interv Radiol. 2000;11(6):767\u201370.","journal-title":"J Vasc Interv Radiol"},{"issue":"1","key":"660_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1148\/radiol.2016152292","volume":"281","author":"T Bilhim","year":"2016","unstructured":"Bilhim T, et al. Predictors of clinical outcome after prostate artery embolization with spherical and nonspherical polyvinyl alcohol particles in patients with benign prostatic hyperplasia. Radiology. 2016;281(1):289\u2013300.","journal-title":"Radiology"},{"issue":"14","key":"660_CR9","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.3390\/jcm10143161","volume":"10","author":"R Loffroy","year":"2021","unstructured":"Loffroy R, et al. Prostate artery embolization using n-butyl cyanoacrylate glue for urinary tract symptoms due to benign prostatic hyperplasia: a valid alternative to microparticles? J Clin Med. 2021;10(14):3161.","journal-title":"J Clin Med"},{"issue":"5","key":"660_CR10","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.jvir.2017.01.004","volume":"28","author":"S Bhatia","year":"2017","unstructured":"Bhatia S, et al. Role of coil embolization during prostatic artery embolization: incidence, indications, and safety profile\u2606. J Vasc Interv Radiol. 2017;28(5):656-664. e3.","journal-title":"J Vasc Interv Radiol"},{"key":"660_CR11","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1007\/s00270-021-02964-5","volume":"44","author":"N Galla","year":"2021","unstructured":"Galla N, et al. Adjunctive coil embolization of the prostatic arteries after particle embolization for prostatic artery embolization. Cardiovasc Intervent Radiol. 2021;44:1994\u20138.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"660_CR12","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1016\/j.jvir.2016.12.973","volume":"28","author":"O Khalilzadeh","year":"2017","unstructured":"Khalilzadeh O, et al. Proposal of a new adverse event classification system by the SIR standards of practice committee. J Vasc Interv Radiol. 2017;28(2):S153.","journal-title":"J Vasc Interv Radiol"},{"issue":"2","key":"660_CR13","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/bju.14249","volume":"122","author":"AF Ray","year":"2018","unstructured":"Ray AF, et al. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int. 2018;122(2):270\u201382.","journal-title":"BJU Int"}],"container-title":["CVIR Endovascular"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-026-00660-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42155-026-00660-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42155-026-00660-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T08:42:59Z","timestamp":1771663379000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42155-026-00660-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,21]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["660"],"URL":"https:\/\/doi.org\/10.1186\/s42155-026-00660-4","relation":{},"ISSN":["2520-8934"],"issn-type":[{"value":"2520-8934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,21]]},"assertion":[{"value":"5 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"IRB approval was obtained prior to completion of this study. Consent for publication is not applicable. IRB protocol number: 18\u20131455. Consent to participate is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All of the authors have reviewed the final manuscript and consent to publication in CVIR Endovascular. This manuscript is not currently submitted for publication in any other journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Justin P. McWilliams, MD has the following declarations: Lecture fees, Terumo, siemens, penumbra; Consulting for Asahi Intecc, Boston Scientific. All other authors do not have any conflicts of interest to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}